NCT03539640

Brief Summary

This study evaluates the effect of positive end-expiratory pressure on the position, length and function of the diaphragm. During the first part of the study, physiological measurements of the diaphragm will be performed while participants receive non-invasive ventilation at different PEEP levels. During the second part of the study, MRI measurements of the diaphragm will be performed during a change in PEEP level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2018

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 29, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

May 20, 2020

Status Verified

May 1, 2020

Enrollment Period

8 months

First QC Date

April 17, 2018

Last Update Submit

May 19, 2020

Conditions

Keywords

PEEPDiaphragm

Outcome Measures

Primary Outcomes (4)

  • Changes in diaphragm's position

    Changes in the position of the diaphragm during different PEEP levels, as measured with both ultrasound and MRI

    2 hours

  • Changes in diaphragm's shape and length

    Changes of the diaphragm's shape and length during different PEEP levels, as measured with MRI

    2 hours

  • Changes in diaphragm's efficiency

    Changes in the neuro-mechanical efficiency of the diaphragm (ratio between pressure and electrical muscle activity) during different PEEP levels, as measured with a nasogastric catheter

    2 hours

  • Change in twitch transdiaphragmatic pressures

    Twitch transdiaphragmatic pressures during different PEEP levels, as measured with magnetic stimulation of the phrenic nerves.

    2 hours

Secondary Outcomes (1)

  • Difference between MRI and ultrasound

    2 hours

Other Outcomes (2)

  • Expiratory abdominal muscle activity

    2 hours

  • Flow

    2 hours

Study Arms (3)

PEEP level of 5 cmH2O

ACTIVE COMPARATOR

During second part of the study (MRI) Diaphragm position

Other: PEEP: 5 cmH2O

PEEP level of 10 cmH2O

ACTIVE COMPARATOR

During second part of the study (MRI) Diaphragm position

Other: PEEP: 10 cmH2O

PEEP level of 15 cmH2O

ACTIVE COMPARATOR

During second part of the study (MRI) Diaphragm position

Other: PEEP: 15 cmH2O

Interventions

During second part of the study (MRI)

PEEP level of 5 cmH2O

During second part of the study (MRI)

PEEP level of 10 cmH2O

During second part of the study (MRI)

PEEP level of 15 cmH2O

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent
  • Age ≥ 18 years

You may not qualify if:

  • Symptoms relating to respiratory or cardiovascular disease
  • History of pneumothorax or family history of primary pneumothorax
  • Obesity (defined as BMI \> 30kg/m²)
  • Known pregnancy
  • Contraindications for the placement of a nasogastric tube (upper airway/esophageal/gastric/mouth or face pathology (e.g. recent surgery, esophageal varices, diaphragmatic hernia), nasal bleeding within the last 2 weeks or use of anticoagulants)
  • Contraindications for MRI (electrical/metallic implants, claustrophobia or history in metalworking)
  • Subjects who are employed at the department of intensive care adults, directly involved in the study and/or family from staff of the ICU.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VU Medical Center

Amsterdam, North Holland, 1081 HV, Netherlands

Location

Study Officials

  • Leo Heunks, MD, PhD

    Amsterdam UMC, location VUmc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessor of the MRI measurements will analyze the MRI data in a blinded fashion. The rest of the outcomes will not be analyzed in a blinded fashion.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: All participants will receive the same protocol with different levels of PEEP ventilation during the first part of the study (physiological part), so the interventional study model for this part is single group. During the second part (MRI), participants are randomized for one of the three available PEEP levels (5, 10 or 15 cmH2O), so the study model for this part is parallel.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

April 17, 2018

First Posted

May 29, 2018

Study Start

April 13, 2018

Primary Completion

December 12, 2018

Study Completion

May 1, 2019

Last Updated

May 20, 2020

Record last verified: 2020-05

Locations